Vioma Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.75 M
as on 09-12-2024
- Paid Up Capital ₹ 0.68 M
as on 09-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -36.33%
(FY 2022)
- Profit -714.59%
(FY 2022)
- Ebitda -5321.29%
(FY 2022)
- Net Worth -257.63%
(FY 2022)
- Total Assets -30.03%
(FY 2022)
About Vioma Lifesciences
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.75 M and a paid-up capital of Rs 0.68 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vioma Lifesciences Private Limited India is Jyoti Singha as CEO. Jyoti Singha and Raj Ningthemngambi serve as directors at the Company.
- CIN/LLPIN
U74999MH2017PTC295120
- Company No.
295120
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Vioma Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Singha  | CEO | 06-Jul-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jyoti Singha | Director and Ceo | 19-May-2017 | Current |
| Raj Ningthemngambi | Director | 11-Jan-2019 | Current |
Financial Performance and Corporate Structure Insights of Vioma Lifesciences.
Vioma Lifesciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 36.33% decrease. The company also saw a substantial fall in profitability, with a 714.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 257.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vioma Lifesciences?
In 2022, Vioma Lifesciences had a promoter holding of 20.02% and a public holding of 79.98%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hwell24 Business Services Private LimitedActive 6 years 10 monthsJyoti Singha and Raj Ningthemngambi are mutual person
Wnes Ventures Advisors Private LimitedActive 5 years 9 monthsJyoti Singha and Raj Ningthemngambi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vioma Lifesciences?
Unlock and access historical data on people associated with Vioma Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vioma Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vioma Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
